Skip to content

Leading figures in the industry push for groundbreaking solutions to aid those affected by rare and neglected illnesses during the COVID-19 pandemic

FFF Enterprises and BioNews Services unveil plans for latest-technology innovations in the clinical trial process for rare and persistent illnesses.

Pioneers in the industry aim to push forward groundbreaking solutions for the communities affected...
Pioneers in the industry aim to push forward groundbreaking solutions for the communities affected by rare and orphan diseases during the ongoing COVID-19 pandemic.

Leading figures in the industry push for groundbreaking solutions to aid those affected by rare and neglected illnesses during the COVID-19 pandemic

In the face of the ongoing pandemic, many patients served by FFF Enterprises have expressed fear about letting nurses come to their homes for treatments. Recognizing this need, FFF Enterprises has identified the importance of serving rare and orphan disease patient communities during these challenging times.

To address this issue, FFF Enterprises has partnered with Bionews Services, an online leader in creating news and perspectives platforms for rare and orphan disease communities. This partnership, which will continue beyond the pandemic, aims to provide hope to those affected by rare and orphan diseases.

FFF Enterprises, a leading supplier of critical-care biopharmaceuticals, plasma products, and vaccines, will work alongside Bionews Services to connect patients with community and health resources. This collaboration is focused on fostering communication and participation in improving health and lives worldwide.

The mandate to self-quarantine has led to social isolation for many patients, and an abrupt halt to participation in critical clinical trials. In response, FFF Enterprises is seeking to partner with digital leaders to help patients connect and know they are not alone.

Bionews Services, with over 65 active websites that publish reliable news and intimate perspectives written by patients daily, will play a crucial role in this partnership. The organization that teamed up with FFF Enterprises to support self-help groups for people with rare and root diseases during the COVID-19 pandemic is the National Organization for Rare Disorders (NORD).

FFF Enterprises has been proactive in communicating with pharmaceutical manufacturers to ensure patients receive lifesaving medicines. They are also reaching out to their patients, reassuring them of their commitment to their health and well-being.

For more information about FFF Enterprises, please contact [email protected]. For media inquiries, you can reach Michelle Valenzuela, Senior Director, Marketing & Communications at [email protected].

Bionews Services invites interested parties to contact them for business development at [company website] or through the company phone. They recognize the isolation experienced by those suffering from chronic, progressive diseases and aim to be a source of light in times of isolation for those most in need. The mission includes providing knowledge, insight, and hope to patients.

Together, FFF Enterprises and Bionews Services aim to be a beacon of hope and support for rare and orphan disease patients, helping them navigate the challenges of the pandemic and beyond.

Read also:

Latest